Immunobiology of gonococcal outer membrane protein I

Area of Science:

• Immunology
• Microbiology
• Vaccine Development

Background:

• Neisseria gonorrhoeae outer membrane protein I (PI) is a key surface antigen.
• PI exhibits strain-specific variations (PI.A and PI.B), complicating vaccine development.
• Developing effective immunoprophylaxis against gonorrhea remains a significant public health challenge.

Purpose of the Study:

• To generate and characterize monoclonal antibodies against conserved epitopes of gonococcal protein I.
• To evaluate the functional efficacy of these antibodies in vitro against Neisseria gonorrhoeae.

Main Methods:

• Production of monoclonal antibodies reactive to gonococcal protein I.
• In vitro assessment of antibody bactericidal activity in the presence of complement.
• Evaluation of antibody-mediated opsonization for phagocytosis by polymorphonuclear leukocytes (PMN).
• Testing the ability of antibodies to protect epithelial cells from gonococcal invasion.

Main Results:

• Two monoclonal antibodies were generated, one targeting PI.A strains and another targeting PI.B strains.
• Both antibodies demonstrated bactericidal activity against Neisseria gonorrhoeae in vitro with complement.
• Antibodies enhanced phagocytosis of gonococci by human PMNs (opsonization).
• Antibodies conferred protection to epithelial cells against gonococcal invasion.

Conclusions:

• Conserved epitopes on gonococcal protein I are viable targets for immunoprophylaxis.
• Monoclonal antibodies against protein I offer a promising strategy for preventing gonorrhea infections.
• Further development of protein I-based vaccines or antibody therapies is warranted.